Hepatitis Forums

Hepatitis C Main Forums => Post Hepatitis C Treatment => Topic started by: Hep Editors on March 16, 2020, 09:55:03 am

Title: Albumin and Liver Stiffness Signal Risk of Liver Cancer After Hep C Cure
Post by: Hep Editors on March 16, 2020, 09:55:03 am
To identify who among those receiving direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) is at elevated risk for liver cancer, look to albumin and liver stiffness levels during the period following treatment, Healio reports.

That’s according to a new study led by Mònica Pons, MD, of the Vall d’Hebron Research Institute in Barcelona, and published in the Journal of Hepatology.

The study analyzed data on 1,563 people who received DAA treatment for HCV, 572 of whom had compensated advanced chronic liver disease. A total of 97.1% achieved a sustained virologic response 12 weeks after completing therapy (SVR12), considered a cure.